TomoTherapy co-founder Reckwerdt retires

TriMed Staff | | Health Imaging | Artificial Intelligence
TomoTherapy has announced that co-founder Paul J. Reckwerdt will retire as president and relinquish his board directorship, effective Dec. 31.

Reckwerdt plans to pursue entrepreneurial opportunities and will serve as a strategic advisor to Compact Particle Acceleration Corporation, which is developing a compact proton therapy system in partnership with TomoTherapy.

Reckwerdt co-founded TomoTherapy with Rock Mackie, PhD, to commercialize a precise form of radiation therapy that the two researched at University of Wisconsin in Madison.

TriMed Staff

Related Content

Mayo Clinic and Microsoft partner to advance generative AI in radiology
Could synthetic images replace the need for contrast?
Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%
Clinicians want AI to show its work

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.